Found: 2
Select item for more details and to access through your institution.
ACCLAIM: A randomized trial of abatacept (CTLA4-Ig) for relapsing-remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2017, v. 23, n. 5, p. 686, doi. 10.1177/1352458516662727
- By:
- Publication type:
- Article
Phase II Randomized Trial of Rituximab Plus Cyclophosphamide Followed by Belimumab for the Treatment of Lupus Nephritis.
- Published in:
- Arthritis & Rheumatology, 2021, v. 73, n. 1, p. 121, doi. 10.1002/art.41466
- By:
- Publication type:
- Article